Biogen

Biogen

Team Size
1–10
Employees
Reuters

NHS England, Biogen reach deal on pricey drug for deadly disorder

Xconomy

Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More

Xconomy

Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More

Xconomy

Biogen, Taking Its Crisis “Seriously,” Keeps Focus on Neuroscience

Reuters

Biogen SMA drug price, Novartis estimates for its treatment far too...

Forbes

How Will The Failure Of Biogen's Alzheimer's Drug, Aducanumab, Impact R&D?

Xconomy

Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More

Reuters

Biogen scraps two Alzheimer drug trials, wipes $18 billion from...

Xconomy , Reuters

Adieux to Adu: Biogen's Big Alzheimer's Bet Flops, Shares Routed

Xconomy

Eisai & Biogen Reveal Promising Alzheimer’s Data, But Questions Linger

Health Science People
Xconomy

Biogen Makes Another Small Bet With Option Deal for TMS Stroke Drug

Health
Xconomy

SMA Day: AveXis Gene Therapy Creeps Forward as Biogen Drug’s Sales Slow

Health Science
Bloomberg Business

Biogen's Strange MS Quandary Requires Stronger Medicine

Health Earnings
Xconomy

Biogen Pays $1B to Broaden Ionis Pact, Betting More on RNA Drugs

Health Strategy
Bloomberg Business

Biogen Drops After Alzheimer's Drug Trial Change Raises Concerns

Health
Bloomberg Business

Biogen's Spinraza: Great Launch, Rough Ride

Health Earnings
Xconomy

Biogen, Eisai Alzheimer’s Drug Fails First Test But Study Continues

Health Science
Xconomy

After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial

Health Strategy
Xconomy

Biogen, Opening Bottlenecks, Sees Spine Drug Sales, Shares Rise

Health Earnings
BostInno

26 Lawsuits from Biogen | 26 Startups Raised $393M in June